Literature DB >> 914841

Biochemical and immunological properties of gag genecoded structural proteins of endogenous tyep C RNA tumor viruses of diverse mammalian species.

J R Stephenson, R K Reynolds, S G Devare, F H Reynolds.   

Abstract

The major nonglycosylated structure proteins of mammalian type C RNA tumor viruses are synthesized in the form of a high molecular weight precursor coded for by a viral gene disignated "gag". Previous genetic analysis of a prototype virus isolated of mouse origin has led to a determination of the internal arragnement of the regions within the gag gene coding for individual structural proteins. In the present study, the biochemical properties of structural proteins of type C virus isolates of additional mammalian species were analyzed. The results obtained indicate that the biochemical properties of immunologically cross-reactive proteins have been highly conserved throughout the evolution of this group of viruses. Moreover, these findings provide a means of mapping the gag genes of a broad range of mammalian type C viruses. In view of the results obtained, a new nomenclature system for type C viral gag gene-coded translational products is proposed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 914841

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Structural analysis of the genomes of gibbon ape and woolly monkey leukosis viruses.

Authors:  B G Sahagan; W A Haseltine
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membrane.

Authors:  E A Pillemer; D A Kooistra; O N Witte; I L Weissman
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

3.  Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein.

Authors:  J R Stephenson; A S Khan; A H Sliski; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  Genomic diversity of the acquired immunodeficiency syndrome retroviruses is reflected in alteration of its translational products.

Authors:  S G Devare; A Srinivasan; C A Bohan; T J Spira; J W Curran; V S Kalyanaraman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Translation of type C viral RNAs in Xenopus laevis oocytes: evidence that the 120,000-molecular-weight polyprotein expressed in Abelson leukemia virus-transformed cells is virus coded.

Authors:  R K Reynolds; W J van de Ven; J R Stephenson
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

6.  Cells nonproductively transformed by Abelson murine leukemia virus express a high molecular weight polyprotein containing structural and nonstructural components.

Authors:  F H Reynolds; T L Sacks; D N Deobagkar; J R Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

7.  Molecular cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences.

Authors:  S M Desai; V S Kalyanaraman; J M Casey; A Srinivasan; P R Andersen; S G Devare
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

8.  Abelson murine leukemia virus transformation-defective mutants with impaired P120-associated protein kinase activity.

Authors:  F H Reynolds; W J Van de Ven; J R Stephenson
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

9.  Primate retroviruses: intracistronic mapping of type D viral gag gene by use of nonconditional replication mutants.

Authors:  S G Devare; J R Stephenson
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

10.  Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.

Authors:  J M Casey; Y Kim; P R Andersen; K F Watson; J L Fox; S G Devare
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.